LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Search

BeOne Medicines Ltd ADR

Closed

SectorHealthcare

325.82 1

Overview

Share price change

24h

Current

Min

322

Max

330.3

Key metrics

By Trading Economics

Income

31M

125M

Sales

97M

1.4B

Profit margin

8.84

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+23.15% upside

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

324.82

Previous close

325.82

News Sentiment

By Acuity

50%

50%

175 / 374 Healthcare

BeOne Medicines Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

17 Nov 2025, 12:16 UTC

Major Market Movers

Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment

12 May 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 Jan 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

6 Nov 2025, 11:01 UTC

Earnings

BeOne Medicines Sees FY25 Rev $5.1B-$5.3B >ONC

6 Nov 2025, 11:01 UTC

Earnings

BeOne Medicines 3Q Adj EPS $2.65 >ONC

6 Nov 2025, 11:01 UTC

Earnings

BeOne Medicines 3Q Rev $1.4B >ONC

6 Nov 2025, 11:00 UTC

Earnings

BeOne Medicines 3Q EPS $1.09 >ONC

6 Aug 2025, 10:01 UTC

Earnings

BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC

6 Aug 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Rev $1.3B >ONC

6 Aug 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Adj EPS $2.25 >ONC

6 Aug 2025, 10:00 UTC

Earnings

BeOne Medicines 2Q EPS 84c >ONC

9 Jul 2025, 09:17 UTC

Hot Stocks

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

7 May 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 May 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 May 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 May 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 May 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 Feb 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

23.15% upside

12 Months Forecast

Average 397.66 USD  23.15%

High 424 USD

Low 362 USD

Based on 13 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Sentiment

By Acuity

175 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd
help-icon Live chat